Prevalence of Helicobacter pylori and its cagA gene in patients with gastric cancer or peptic ulcer at an Iranian medical center
Novelty in Biomedicine,
Vol. 9 No. 1 (2021),
8 February 2021
,
Page 24-27
https://doi.org/10.22037/nbm.vi.32595
Abstract
Background: Iran has a high incidence rate for gastric cancer among the Middle East countries. In addition to gastric cancer, peptic ulcer is also life-threatening; thus, investigating the prevalence of Helicobacter pylori infection and other risk factors are essential. The present study was aimed to assess the frequency of H. pylori and the cagA-positive strains in patients with gastric cancer or peptic ulcer at a teaching hospital in Qom, one of the most populated cities of Iran.Materials and Methods: The presence of H. pylori was investigated in gastric cancer and peptic ulcer biopsy specimens using the standard culture method. PCR analysis was performed to detect the presence of the cagA gene.
Results: The frequency of H. pylori isolates among 86 investigated biopsies was 20 (23.2%). Likewise, the rate of H. pylori was the highest when samples were examined from patients with gastric cancer (25.8%), while it was 21.8% when obtained from peptic ulcer patients. The frequency of the cagA gene in H. pylori isolates was 9 (56.2%), as confirmed by PCR.
Conclusion: Our results indicated that H. Pylori infection and its virulent strains are frequent and widely spread in Qom city. The cagA gene was present in almost half of H. pylori isolates from peptic ulcer or gastric cancer patients. Therefore, it is necessary to screen it in all cases with H. pylori infection for early detection of gastric cancer.
- Helicobacter pylori, cagA, Gastric Cancer, Peptic ulcer, Qom
How to Cite
References
2. Leja, M., et al., Epidemiology of Helicobacter pylori infection. Helicobacter, 2019. 24: p. e12635.
3. Khalifa, M.M., R.R. Sharaf, and R.K. Aziz, Helicobacter pylori: a poor man's gut pathogen? Gut pathogens, 2010. 2(1): p. 2.
4. Kumar, S., et al., Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: A large cohort study. Gastroenterology, 2020. 158(3): p. 527-536. e7.
5. Thrift, A.P. and H.B. El-Serag, Burden of gastric cancer. Clinical Gastroenterology and Hepatology, 2020. 18(3): p. 534-542.
6. Organization, W.H., Biological agents. Volume 100 B. A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer, 2012. 100(Pt B): p. 1-441.
7. Mezmale, L., et al., Epidemiology of Helicobacter pylori. Helicobacter, 2020. 25: p. e12734.
8. Kamogawa-Schifter, Y., et al., Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years. PloS one, 2018. 13(5): p. e0197695.
9. Chmiela, M. and J. Kupcinskas, Pathogenesis of Helicobacter pylori infection. Helicobacter, 2019. 24: p. e12638.
10. Šterbenc, A., et al., Helicobacter pylori virulence genes. World journal of gastroenterology, 2019. 25(33): p. 4870.
11. Javed, S., E.C. Skoog, and J.V. Solnick, Impact of Helicobacter pylori virulence factors on the host immune response and gastric pathology, in Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori. 2019, Springer. p. 21-52.
12. Ansari, S. and Y. Yamaoka, Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins, 2019. 11(11): p. 677.
13. Subsomwong, P., et al., Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand. PloS one, 2017. 12(10): p. e0187113.
14. Aminde, J.A., et al., Helicobacter pylori infection among patients presenting with dyspepsia at a primary care setting in Cameroon: seroprevalence, five-year trend and predictors. BMC Infectious Diseases, 2019. 19(1): p. 30.
15. Sarwar, N., et al., Prevalence of Helicobacter pylori infection and its associated diseases in low socio-economic workers in tertiary care hospital of Lahore, Pakistan. Biomedical Letters, 2019. 5(1): p. 1-6.
16. Takahashi-Kanemitsu, A., C.T. Knight, and M. Hatakeyama, Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cellular & Molecular Immunology, 2019: p. 1-14.
17. Bakhti, S.Z., et al., Which genotype of Helicobacter pylori—cagA or cagE—Is better associated with gastric Cancer risk? Lessons from an extremely high-risk area in Iran. Infection, Genetics and Evolution, 2020. 85: p. 104431.
18. Fujii, Y., N. Murata-Kamiya, and M. Hatakeyama, Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells. Cancer Science, 2020. 111(5): p. 1596.
19. Lan, K.-H., et al., Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeutics-induced apoptosis in gastric cancer cells. Oncotarget, 2017. 8(69): p. 113460.
20. Malekzadeh, R., M.H. Derakhshan, and Z. Malekzadeh, Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 2009. 12(6): p. 576-583
21. Dabiri, H., et al., Prevalence of Helicobacter pylori vacA, cagA, cagE, oipA, iceA, babA2 and babB genotypes in Iranian dyspeptic patients. Microbial pathogenesis, 2017. 105: p. 226-230.
22. Bakhti, S.Z., S. Latifi-Navid, and S. Zahri, Unique constellations of five polymorphic sites of Helicobacter pylori vacA and cagA status associated with risk of gastric cancer. Infection, Genetics and Evolution, 2020. 79: p. 104167.
23. Lu, J.-J., et al., Comparison of Five PCR Methods for Detection ofHelicobacter pylori DNA in Gastric Tissues. Journal of clinical microbiology, 1999. 37(3): p. 772-774.
24. Castaneda, C.A., et al., Prevalence of Helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in Peruvian patients with chronic gastritis and gastric cancer. Journal of global oncology, 2019. 5: p. 1-9.
25. Bibi, F., et al., Detection and genotyping of Helicobacter pylori among gastric ulcer and cancer patients from Saudi Arabia. Pakistan journal of medical sciences, 2017. 33(2): p. 320.
26. El-Khlousy, M., et al., Study of the clinical relevance of Helicobacter pylori virulence genes to gastric diseases among Egyptian patients. Arab Journal of Gastroenterology, 2016. 17(2): p. 90-94.
27. Nimri, L.F., et al., Helicobacter pylori genotypes identified in gastric biopsy specimens from Jordanian patients. BMC gastroenterology, 2006. 6(1): p. 1-6.
28. Ekström, A.M., et al., Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology, 2001. 121(4): p. 784-791.
29. Li, N., et al., Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway. Journal of Experimental & Clinical Cancer Research, 2018. 37(1): p. 1-15.
30. Batista, S.A., et al., Higher number of Helicobacter pylori CagA EPIYA C phosphorylation sites increases the risk of gastric cancer, but not duodenal ulcer. BMC microbiology, 2011. 11(1): p. 61.
31. Meine, G.C., et al., Relationship between cagA-positive Helicobacter pylori infection and risk of gastric cancer: a case control study in Porto Alegre, RS, Brazil. Arquivos de gastroenterologia, 2011. 48(1): p. 41-45.
32. Miehlke, S., et al., The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. International journal of cancer, 2000. 87(3): p. 322-327.
33. Román-Román, A., et al., Helicobacter pylori vacA s1m1 genotype but not cagA or babA2 increase the risk of ulcer and gastric cancer in patients from Southern Mexico. Gut pathogens, 2017. 9(1): p. 18.
34. Held, M., et al., Is the association between Helicobacter pylori and gastric cancer confined to CagA‐positive strains? Helicobacter, 2004. 9(3): p. 271-277.
35. Al-Eraky, D.M., et al., Prevalence of CagA and antimicrobial sensitivity of H. pylori isolates of patients with gastric cancer in Egypt. Infectious agents and cancer, 2018. 13(1): p. 24.
- Abstract Viewed: 230 times
- PDF Downloaded: 137 times